| Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ... The lancet oncology 10 (1), 35-43, 2009 | 2196 | 2009 |
| The international position on laparoscopic liver surgery: The Louisville Statement, 2008 JF Buell, D Cherqui, DA Geller, N O’rourke, D Iannitti, I Dagher, AJ Koffron, ... Annals of surgery 250 (5), 825-830, 2009 | 1827 | 2009 |
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ... New England Journal of Medicine 359 (19), 1995-2004, 2008 | 1340 | 2008 |
| Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial J Bruix, T Takayama, V Mazzaferro, GY Chau, J Yang, M Kudo, J Cai, ... The lancet oncology 16 (13), 1344-1354, 2015 | 1060 | 2015 |
| Pivotal role of mTOR signaling in hepatocellular carcinoma A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ... Gastroenterology 135 (6), 1972-1983. e11, 2008 | 832 | 2008 |
| Focal gains of VEGFA and molecular classification of hepatocellular carcinoma DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ... Cancer research 68 (16), 6779-6788, 2008 | 749 | 2008 |
| Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis P Tabrizian, G Jibara, B Shrager, M Schwartz, S Roayaie Annals of surgery 261 (5), 947-955, 2015 | 736 | 2015 |
| Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma E Wurmbach, Y Chen, G Khitrov, W Zhang, S Roayaie, M Schwartz, I Fiel, ... Hepatology 45 (4), 938-947, 2007 | 734 | 2007 |
| A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma S Roayaie, IN Blume, SN Thung, M Guido, MI Fiel, S Hiotis, DM Labow, ... Gastroenterology 137 (3), 850-855, 2009 | 671 | 2009 |
| Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes D Sia, Y Hoshida, A Villanueva, S Roayaie, J Ferrer, B Tabak, J Peix, ... Gastroenterology 144 (4), 829-840, 2013 | 576 | 2013 |
| Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters S Roayaie, JS Frischer, SH Emre, TM Fishbein, PA Sheiner, M Sung, ... Annals of surgery 235 (4), 533-539, 2002 | 509 | 2002 |
| Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis S Roayaie, JD Schwartz, MW Sung, SH Emre, CM Miller, GE Gondolesi, ... Liver Transplantation 10 (4), 534-540, 2004 | 502 | 2004 |
| A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis JM Llovet, Y Chen, E Wurmbach, S Roayaie, MI Fiel, M Schwartz, ... Gastroenterology 131 (6), 1758-1767, 2006 | 463 | 2006 |
| Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ... Gastroenterology 140 (5), 1501-1512. e2, 2011 | 456 | 2011 |
| Resection of hepatocellular cancer≤ 2 cm: results from two Western centers S Roayaie, K Obeidat, C Sposito, L Mariani, S Bhoori, A Pellegrinelli, ... Hepatology 57 (4), 1426-1435, 2013 | 428 | 2013 |
| Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection AWH Chan, J Zhong, S Berhane, H Toyoda, A Cucchetti, KQ Shi, T Tada, ... Journal of hepatology 69 (6), 1284-1293, 2018 | 417 | 2018 |
| The role of hepatic resection in the treatment of hepatocellular cancer S Roayaie, G Jibara, P Tabrizian, JW Park, J Yang, L Yan, M Schwartz, ... Hepatology 62 (2), 440-451, 2015 | 402 | 2015 |
| Strategies for the management of hepatocellular carcinoma M Schwartz, S Roayaie, M Konstadoulakis Nature clinical practice Oncology 4 (7), 424-432, 2007 | 370 | 2007 |
| Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma D Sia, B Losic, A Moeini, L Cabellos, K Hao, K Revill, D Bonal, ... Nature communications 6 (1), 6087, 2015 | 304 | 2015 |
| Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo P Newell, S Toffanin, A Villanueva, DY Chiang, B Minguez, L Cabellos, ... Journal of hepatology 51 (4), 725-733, 2009 | 273 | 2009 |
